Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last C$0.41 CAD
Change Today +0.06 / 17.14%
Volume 210.3K
HTL On Other Exchanges
As of 3:55 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

hamilton thorne ltd (HTL) Snapshot

Previous Close
Day High
Day Low
52 Week High
01/14/15 - C$0.51
52 Week Low
08/25/14 - C$0.05
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for HAMILTON THORNE LTD (HTL)

Related News

No related news articles were found.

hamilton thorne ltd (HTL) Related Businessweek News

No Related Businessweek News Found

hamilton thorne ltd (HTL) Details

Hamilton Thorne Ltd. designs, manufactures, and distributes precision laser devices and image analysis systems for fertility, stem cell, and development biology research markets. Its products include clinical and research lasers, clinical sperm analysis products, animal and research sperm analysis products, sperm analyzer options, sperm analysis accessories, automated software solutions for live sperm morphology, and oosight imaging systems; and CIVA software to capture images/video and annotate. The company offers products for clinical laser applications, such as laser-assisted hatching and embryo biopsy; research laser applications, including transgenic animal production, stem cell applications, somatic cell nuclear transfer, developmental biology, and adherent cell culture; sperm analysis applications, such as fertility testing, reproductive toxicology, animal breeding, and biological research; and intracytoplasmic morphologically selected sperm injection. It offers products through distributors to pharmaceutical and biotechnology companies, fertility clinics, university research centers, and other commercial and academic research establishments worldwide. The company is based in Beverly, Massachusetts.

hamilton thorne ltd (HTL) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $189.6K
Co-Founder, Chief Technology Officer, Corpora...
Total Annual Compensation: $141.6K
Chief Financial Officer and Vice President of...
Total Annual Compensation: $154.0K
Vice President of Engineering
Total Annual Compensation: $140.0K
Compensation as of Fiscal Year 2013.

hamilton thorne ltd (HTL) Key Developments

Hamilton Thorne Ltd. Announces That the Company Now Offers the Oosight Product Line

Hamilton Thorne Ltd. announced that the company now offers the Oosight product line, which it has acquired from Cambridge Research & Instrumentation Inc. (CRi). The Oosight system provides high-contrast live images of unfertilized eggs (oocytes),capturing quantitative data of important structures using a patented non-invasive, polarized-light technique developed by the Marine Biological Laboratory and commercialized by CRi as LC-PolScopeTM technology. The Oosight system's visualization capabilities have enabled breakthroughs in assisted reproductive technology, stem cell generation and developmental biology research.

Hamilton Thorne Announces Revenue Results for the Fourth Quarter Ended December 31, 2014; Provides Earnings Guidance for the Fourth Quarter and Full Year Ended December 31, 2014 and for the Year 2015

Hamilton Thorne Ltd. announced preliminary unaudited sales results for the fourth quarter ended December 31, 2014. For the quarter, sales grew 10% to approximately $2.5 million versus the same quarter a year ago, the ninth consecutive quarter of growth. For the year 2014, the company is expecting to report net income of over $800,000, a five-fold increase over $125,000 of net income in the prior year, and EBITDA in excess of $1,000,000. Net income and EBITDA are expected to be over $400,000 and $500,000 respectively for the fourth quarter. The financial information is based on management's estimates and is subject to adjustment. The company expects continued growth in both revenues and profitability in 2015 but the level of growth will be dependent upon general economic conditions and, given strong export sales, the US dollar's value versus other major currencies.

Hamilton Thorne Ltd. to Report Fiscal Year 2014 Results on Apr 24, 2015

Hamilton Thorne Ltd. announced that they will report fiscal year 2014 results at 1:20 PM, GMT Standard Time on Apr 24, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HTL:CN C$0.41 CAD +0.06

HTL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Brooks Automation Inc $10.90 USD -0.22
Tsubakimoto Chain Co ¥996.00 JPY +1.00
View Industry Companies

Industry Analysis


Industry Average

Valuation HTL Industry Range
Price/Earnings 22.7x
Price/Sales 1.8x
Price/Book NM Not Meaningful
Price/Cash Flow 25.8x
TEV/Sales 1.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HAMILTON THORNE LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at